As we know GRK2 is upregulated in various kidney diseases, GRK2 inhibition might be an innovative therapeutic strategy to treat renal diseases, such as SLE‐related kidney injury, DN, age‐related kidney injury, hypertension‐related kidney injury, and CRS. This evidence concerns the gene GRK2 and kidney disorder.